Showing results (601-610 of 648) with videos related to
Sort By:
Pageof 65
Plos One|June 3, 2014
Chromatin CKAP2, a new proliferation marker, as independent prognostic indicator in breast cancerHan-Seong Kim, Jae-Soo Koh, Yong-Bock Choi, et al.Nature Communications|June 6, 2026
Correlated singular flat bands on the surface pentagonal lattice of ferromagnetic CoS2Yuting Qian, Younsik Kim, Du Hyung Kim, et al.The American Journal of Cardiology|June 16, 2015
Relation of Dietary Glycemic Index and Glycemic Load to Coronary Artery Calcium in Asymptomatic Korean AdultsYuni Choi, Yoosoo Chang, Seungho Ryu, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|March 24, 2011
Sequential therapy with JX-594, a targeted oncolytic poxvirus, followed by sorafenib in hepatocellular carcinoma: preclinical and clinical demonstration of combination efficacyJeong Heo, Caroline J Breitbach, Anne Moon, et al.Cancers|June 10, 2023
Exploring Connections between Oral Microbiota, Short-Chain Fatty Acids, and Specific Cancer Types: A Study of Oral Cancer, Head and Neck Cancer, Pancreatic Cancer, and Gastric CancerZahra Nouri, Sung Weon Choi, Il Ju Choi, et al.Atherosclerosis|July 10, 2009
Cilostazol inhibits high glucose- and angiotensin II-induced type 1 plasminogen activator inhibitor expression in artery wall and neointimal region after vascular injuryKyeong-Min Lee, Hyo-Jeong Lee, Mi-Kyung Kim, et al.Diabetes, Obesity & Metabolism|May 15, 2020
Efficacy and safety of lobeglitazone versus sitagliptin as an add-on to metformin in patients with type 2 diabetes with two or more components of metabolic syndrome over 24 weeksSin Gon Kim, Kyoung Jin Kim, Kun Ho Yoon, et al.Endocrinology and Metabolism (Seoul, Korea)|October 13, 2023
2023 Korean Endocrine Society Consensus Guidelines for the Diagnosis and Management of Primary AldosteronismJeonghoon Ha, Jung Hwan Park, Kyoung Jin Kim, et al.BMC Infectious Diseases|May 16, 2013
Pulmonary actinomycosis during the first decade of 21st century: cases of 94 patientsSo Ri Kim, Lae Young Jung, In-Jae Oh, et al.European Journal of Pharmacology|August 30, 2008
PAR-5359, a well-balanced PPARalpha/gamma dual agonist, exhibits equivalent antidiabetic and hypolipidemic activities in vitro and in vivoMi-Kyung Kim, Yu Na Chae, Moon Ho Son, et al.Pageof 65